Swapnil Parashram Bhavsar
Overview
Explore the profile of Swapnil Parashram Bhavsar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
29
Followers
0
Related Specialties
Related Specialties
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhavsar S, Morini M
Front Oncol
. 2024 Jul;
14:1414063.
PMID: 38962276
Exosomes are a subclass of extracellular vesicles shown to promote the cancer growth and support metastatic progression. The proteomic analysis of neuroblastoma-derived exosomes has revealed proteins involved in cell migration,...
2.
Bhavsar S
Front Oncol
. 2023 Jun;
13:1196861.
PMID: 37274289
Oncogenic drivers like in neuroblastoma subsets continues to present a significant challenge owing to its strong correlation with high-risk metastatic disease and poor prognosis. However, only a limited number of...
3.
Bhavsar S, Olsen L, Lokke C, Koster J, Flaegstad T, Einvik C
Front Pediatr
. 2023 Apr;
11:1098999.
PMID: 37033189
Background: Studies conducted in the last decades have revealed a role for the non-coding microRNAs (miRNAs) in cancer development and progression. Several miRNAs within the chromosome region 14q32, a region...
4.
Bhavsar S
Front Oncol
. 2023 Feb;
12:1091847.
PMID: 36793342
Exosomal miRNAs (exo-miRs), universally found in biofluids, tissues, and/or conditioned medium of the cell cultures play a significant role in cell - cell communication, thus driving cancer progression and metastasis....
5.
Bhavsar S, Lokke C, Flaegstad T, Einvik C
Oncol Lett
. 2018 Nov;
16(5):6786-6794.
PMID: 30405823
High-risk neuroblastoma is the most aggressive form of cancer in children. The estimated survival of children with high-risk neuroblastoma is 40-50% compared with low and intermediate risk neuroblastoma, which is...